LIVINGSTON MARK S. (Chief Financial Officer) sold 0.4% of their position (213.00 shares) of PROGYNY, INC. on the open market
Open‑market sale worth $5.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001551306-25-000207
Officer· Chief Financial Officer
Since Sep 2020
-437.00
Net shares
Net seller
$11.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
437.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−224.00
Price / share
$25.27
Trade value
$5.66K
% of position
0.5%
12/2/2025
48.36K→48.13K
Common Stock
Direct
Shares
−213.00
Price / share
$25.50
Trade value
$5.43K
% of position
0.4%
12/2/2025
48.13K→47.92K
Total
Net shares
−437.00
Net value
-$11.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2025 | F · Tax Withholding | −224.00 | $25.27 | $5.66K | 0.5% | 48.36K | 48.13K |
| Common Stock Direct | 12/2/2025 | S · Sale | −213.00 | $25.50 | $5.43K | 0.4% | 48.13K | 47.92K |
| Total | −437.00 | -$11.09K | ||||||
Derivative Transactions0
No derivative transactions reported